Cerus Corporation (CERS) earnings
CERS earnings moved a median of 0.00% by the close. Quarterly and annual CERS reports and results, each read against the price at its own news timestamp. Back to the CERS overview →
32 measured CERS earnings events.
Where these CERS earnings landedvs 32 measured CERS earnings reactions
| Middle 50% of CERS earnings reactions | -3.83% to +4.24% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 CERS earnings events with a measured close landed between -3.83% and +4.24%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cerus Corporation Announces Second Quarter 2026 Financial Results | Press release | -9.35% | -12.60% | |
| Form 10-Q CERUS CORP For: Jun 30 | SEC filing · Form 10-Q | -9.35% | -12.60% | |
| Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026 | Press release | +0.47% | -1.26% | |
| Cerus Corporation Announces First Quarter 2026 Financial Results | Press release | +13.62% | +1.49% | |
| Form 10-Q CERUS CORP For: Mar 31 | SEC filing · Form 10-Q | +13.62% | +1.49% | |
| Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026 | Press release | -0.48% | +0.48% | |
| Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results | Press release | -6.87% | -0.47% | |
| Form 10-K CERUS CORP For: Dec 31 | SEC filing · Form 10-K | -6.87% | -0.47% | |
| Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance | Press release | +5.94% | +19.58% | |
| Form 10-Q CERUS CORP For: Sep 30 | SEC filing · Form 10-Q | +5.94% | +19.58% | |
| Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.96% | -1.92% | |
| Cerus Corporation Announces Second Quarter 2025 Financial Results | Press release | -1.17% | +0.78% | |
| Form 10-Q CERUS CORP For: Jun 30 | SEC filing · Form 10-Q | -1.17% | +0.78% | |
| Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 | Press release | -0.34% | -0.69% | |
| Cerus Corporation Announces First Quarter 2025 Financial Results | Press release | +5.46% | +5.47% | |
| Form 10-Q CERUS CORP For: Mar 31 | SEC filing · Form 10-Q | +5.46% | +5.47% | |
| Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 | Press release | +0.77% | +0.00% | |
| Form 10-K CERUS CORP For: Dec 31 | SEC filing · Form 10-K | +0.92% | -2.45% | |
| Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results | Press release | +4.52% | -6.78% | |
| Form 10-Q CERUS CORP For: Sep 30 | SEC filing · Form 10-Q | +0.63% | -3.80% | |
| Cerus Corporation Announces Third Quarter 2024 Financial Results | Press release | -1.39% | -12.78% | |
| Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 | Press release | -0.66% | +4.29% | |
| Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range | Press release | +2.33% | +9.07% | |
| Form 10-Q CERUS CORP For: Jun 30 | SEC filing · Form 10-Q | +2.33% | +9.07% | |
| Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024 | Press release | +1.09% | -3.91% | |
| Cerus Corporation Announces First Quarter 2024 Financial Results | Press release | +1.10% | -10.99% | |
| Form 10-Q CERUS CORP For: Mar 31 | SEC filing · Form 10-Q | +1.10% | -10.99% | |
| Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 | Press release | -1.23% | +0.00% | |
| Form 10-K CERUS CORP For: Dec 31 | SEC filing · Form 10-K | +1.40% | +13.08% | |
| Cerus Corporation Announces Third Quarter 2023 Financial Results | Press release | +0.60% | +4.22% | |
| Form 10-Q CERUS CORP For: Sep 30 | SEC filing · Form 10-Q | +0.60% | +4.22% | |
| Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023 | Press release | -3.88% | -4.58% |
Keep exploring
More CERS: analyst actions → · SEC filings → · CERS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Xeris Biopharma Holdings, Inc. (XERS) | 256 | +0.32% | 57% |
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.